Cathie Wood started to build up the position in Surface Oncology in Q3 2020 and continued to invest until Q3 2022. Since then they sold 6.04 Million shares. The investor completely sold their stake between Q4 2022 and Q3 2023.
Avg closing price
Price range
Sold -1.41 Million shares
Q3 2023
Avg closing price
$0.97
Price range
$0.88
-
$1.08
Sold 74.3% shares (-4.08 Million shares)
Q2 2023
Avg closing price
$0.71
Price range
$0.57
-
$0.88
Sold 1.3% shares (-71.1 Thousand shares)
Q1 2023
Avg closing price
$0.81
Price range
$0.61
-
$1.03
Sold 7.8% shares (-468 Thousand shares)
Q4 2022
Avg closing price
$0.99
Price range
$0.62
-
$1.35
Increased shares by 8.6% (+478 Thousand shares)
Q3 2022
Avg closing price
$1.60
Price range
$1.03
-
$2.10
Increased shares by 4.0% (+214 Thousand shares)
Q2 2022
Avg closing price
$2.08
Price range
$1.42
-
$3.15
Increased shares by 0.3% (+17 Thousand shares)
Q1 2022
Avg closing price
$3.50
Price range
$2.65
-
$5.08
Increased shares by 15.3% (+708 Thousand shares)
Q4 2021
Avg closing price
$6.45
Price range
$4.73
-
$7.90
Increased shares by 3.1% (+140 Thousand shares)
Q3 2021
Avg closing price
$6.40
Price range
$5.16
-
$7.98
Increased shares by 10.1% (+409 Thousand shares)
Q2 2021
Avg closing price
$7.71
Price range
$6.45
-
$9.09
Increased shares by 60.1% (+1.53 Million shares)
Q1 2021
Avg closing price
$10.00
Price range
$7.25
-
$13.82
Increased shares by 459.9% (+2.09 Million shares)
Q4 2020